1. Home
  2. NXJ vs BBNX Comparison

NXJ vs BBNX Comparison

Compare NXJ & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New Jersey Qualified Municipal Fund

NXJ

Nuveen New Jersey Qualified Municipal Fund

HOLD

Current Price

$12.47

Market Cap

503.5M

Sector

Finance

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$11.54

Market Cap

555.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXJ
BBNX
Founded
1999
2015
Country
United States
United States
Employees
N/A
423
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
503.5M
555.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NXJ
BBNX
Price
$12.47
$11.54
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$26.73
AVG Volume (30 Days)
112.1K
1.2M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
3.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$35.03
Revenue Next Year
N/A
$33.24
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.01
$8.89
52 Week High
$12.90
$32.71

Technical Indicators

Market Signals
Indicator
NXJ
BBNX
Relative Strength Index (RSI) 40.50 25.65
Support Level $11.24 N/A
Resistance Level $12.76 $15.53
Average True Range (ATR) 0.09 0.95
MACD -0.01 0.18
Stochastic Oscillator 17.21 6.44

Price Performance

Historical Comparison
NXJ
BBNX

About NXJ Nuveen New Jersey Qualified Municipal Fund

Nuveen New Jersey Quality Municipal Income Fund is a closed-end investment management company. Its objective is to provide current income exempt from regular federal and New Jersey income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued. The company invests a majority of its managed assets in securities rated, at the time of investment, investment grade or, if the bonds are unrated, are judged by the manager to be of comparable quality.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.

Share on Social Networks: